Cargando…

Pure ICL Implantation: A Novel Ophthalmic Viscosurgical Device-Free Method

PURPOSE: To assess the clinical efficiency of a novel ophthalmic viscosurgical device-free (OVD-free) method for intraocular collamer lens (EVO-ICL) implantation in myopic eyes. METHODS: In this study, 40 patients underwent ICL implantation for both eyes: one eye underwent traditional ICL implantati...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Qin, Bao, Lianyun, He, Zifang, Chen, Feifei, Zhu, Dandan, Zhang, Si, Zhang, Wenwen, Liu, Yajun, Gao, Ruiying, Xie, Zhenggao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514915/
https://www.ncbi.nlm.nih.gov/pubmed/34659826
http://dx.doi.org/10.1155/2021/7363267
_version_ 1784583501347028992
author Qin, Qin
Bao, Lianyun
He, Zifang
Chen, Feifei
Zhu, Dandan
Zhang, Si
Zhang, Wenwen
Liu, Yajun
Gao, Ruiying
Xie, Zhenggao
author_facet Qin, Qin
Bao, Lianyun
He, Zifang
Chen, Feifei
Zhu, Dandan
Zhang, Si
Zhang, Wenwen
Liu, Yajun
Gao, Ruiying
Xie, Zhenggao
author_sort Qin, Qin
collection PubMed
description PURPOSE: To assess the clinical efficiency of a novel ophthalmic viscosurgical device-free (OVD-free) method for intraocular collamer lens (EVO-ICL) implantation in myopic eyes. METHODS: In this study, 40 patients underwent ICL implantation for both eyes: one eye underwent traditional ICL implantation, and the other eye underwent OVD-free (pure) ICL implantation. Preoperative and postoperative UDVA, BCVA, equivalent spherical degree (SE), IOP, visual quality index, subjective visual quality scale, corneal endothelial cell density (ECD), operation time, and complications were compared between and within the traditional and pure ICL implantation groups. RESULTS: Increased IOP >22 mmHg 2 h after surgery was noted in 8 eyes (20%) in the traditional group, but not in the pure group (0%, P < 0.001). Increased IOP relative to baseline was significantly higher at 2 h after surgery for the traditional group compared with the pure group (P < 0.001). UDVA, BCVA, and SE were significantly improved in the pure group compared with those in the traditional group 1 day (P < 0.001, P=0.003) after implantation, but not 1 week or 3 months after. Modulation transfer function cut-off frequency (MTF cut-off), Strehl ratio (SR), and OV20% were significantly better in the pure group than in the traditional group 1 day after implantation (P=0.013, P=0.009, and P=0.004). No significant difference in ECD changes within or between groups was observed (P > 0.05). The operation time for the pure group (2.897 ± 0.346 min) was significantly shorter than that for the traditional group (4.444 ± 0.656 min; P < 0.001). No complications were reported for either group during the observation period, except early IOP elevation in the traditional group. CONCLUSIONS: The pure ICL implantation method was associated with faster visual acuity recovery, shorter operation time, and more stable intraocular pressure. Pure ICL represents a safe and convenient method for ICL implantation compared with the traditional method, completely eliminating OVD-related complications without causing additional complications.
format Online
Article
Text
id pubmed-8514915
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-85149152021-10-15 Pure ICL Implantation: A Novel Ophthalmic Viscosurgical Device-Free Method Qin, Qin Bao, Lianyun He, Zifang Chen, Feifei Zhu, Dandan Zhang, Si Zhang, Wenwen Liu, Yajun Gao, Ruiying Xie, Zhenggao J Ophthalmol Research Article PURPOSE: To assess the clinical efficiency of a novel ophthalmic viscosurgical device-free (OVD-free) method for intraocular collamer lens (EVO-ICL) implantation in myopic eyes. METHODS: In this study, 40 patients underwent ICL implantation for both eyes: one eye underwent traditional ICL implantation, and the other eye underwent OVD-free (pure) ICL implantation. Preoperative and postoperative UDVA, BCVA, equivalent spherical degree (SE), IOP, visual quality index, subjective visual quality scale, corneal endothelial cell density (ECD), operation time, and complications were compared between and within the traditional and pure ICL implantation groups. RESULTS: Increased IOP >22 mmHg 2 h after surgery was noted in 8 eyes (20%) in the traditional group, but not in the pure group (0%, P < 0.001). Increased IOP relative to baseline was significantly higher at 2 h after surgery for the traditional group compared with the pure group (P < 0.001). UDVA, BCVA, and SE were significantly improved in the pure group compared with those in the traditional group 1 day (P < 0.001, P=0.003) after implantation, but not 1 week or 3 months after. Modulation transfer function cut-off frequency (MTF cut-off), Strehl ratio (SR), and OV20% were significantly better in the pure group than in the traditional group 1 day after implantation (P=0.013, P=0.009, and P=0.004). No significant difference in ECD changes within or between groups was observed (P > 0.05). The operation time for the pure group (2.897 ± 0.346 min) was significantly shorter than that for the traditional group (4.444 ± 0.656 min; P < 0.001). No complications were reported for either group during the observation period, except early IOP elevation in the traditional group. CONCLUSIONS: The pure ICL implantation method was associated with faster visual acuity recovery, shorter operation time, and more stable intraocular pressure. Pure ICL represents a safe and convenient method for ICL implantation compared with the traditional method, completely eliminating OVD-related complications without causing additional complications. Hindawi 2021-10-06 /pmc/articles/PMC8514915/ /pubmed/34659826 http://dx.doi.org/10.1155/2021/7363267 Text en Copyright © 2021 Qin Qin et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Qin, Qin
Bao, Lianyun
He, Zifang
Chen, Feifei
Zhu, Dandan
Zhang, Si
Zhang, Wenwen
Liu, Yajun
Gao, Ruiying
Xie, Zhenggao
Pure ICL Implantation: A Novel Ophthalmic Viscosurgical Device-Free Method
title Pure ICL Implantation: A Novel Ophthalmic Viscosurgical Device-Free Method
title_full Pure ICL Implantation: A Novel Ophthalmic Viscosurgical Device-Free Method
title_fullStr Pure ICL Implantation: A Novel Ophthalmic Viscosurgical Device-Free Method
title_full_unstemmed Pure ICL Implantation: A Novel Ophthalmic Viscosurgical Device-Free Method
title_short Pure ICL Implantation: A Novel Ophthalmic Viscosurgical Device-Free Method
title_sort pure icl implantation: a novel ophthalmic viscosurgical device-free method
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514915/
https://www.ncbi.nlm.nih.gov/pubmed/34659826
http://dx.doi.org/10.1155/2021/7363267
work_keys_str_mv AT qinqin pureiclimplantationanovelophthalmicviscosurgicaldevicefreemethod
AT baolianyun pureiclimplantationanovelophthalmicviscosurgicaldevicefreemethod
AT hezifang pureiclimplantationanovelophthalmicviscosurgicaldevicefreemethod
AT chenfeifei pureiclimplantationanovelophthalmicviscosurgicaldevicefreemethod
AT zhudandan pureiclimplantationanovelophthalmicviscosurgicaldevicefreemethod
AT zhangsi pureiclimplantationanovelophthalmicviscosurgicaldevicefreemethod
AT zhangwenwen pureiclimplantationanovelophthalmicviscosurgicaldevicefreemethod
AT liuyajun pureiclimplantationanovelophthalmicviscosurgicaldevicefreemethod
AT gaoruiying pureiclimplantationanovelophthalmicviscosurgicaldevicefreemethod
AT xiezhenggao pureiclimplantationanovelophthalmicviscosurgicaldevicefreemethod